Css LLC Cyteir Therapeutics, Inc. Transaction History

Css LLC

  • $999 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$2.84 - $3.13 $4,813 - $5,305
-1,695 Reduced 2.97%
55,359 $168,000
Q3 2023

Nov 14, 2023
SELL
$2.71 - $2.84 $9,214 - $9,656
-3,400 Reduced 5.62%
57,054 $162,000
Q2 2023

Aug 14, 2023
BUY
$1.74 - $2.6 $105,189 - $157,180
60,454 New
60,454 $157,000

Others Institutions Holding CYT

# of Institutions
2
Shares Held
2.47M
Call Options Held
0
Put Options Held
0
View Full List

About Cyteir Therapeutics, Inc.

CYT Quotes by TradingView
  • Ticker CYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,413,400
  • Market Cap $107M
  • Description
  • Cyteir Therapeutics, Inc., a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for c...
More about CYT
Track This Portfolio

Track Css LLC Portfolio

Follow Css LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

News

Stay updated on Css LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email